Consent to the Distribution of a New Medicine

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:

Schedule

*Product:*	Idelvion
Active Ingredient:	Albutrepenonacog alfa 3500IU
Dosage Form:	Powder for injection with diluent
New Zealand Sponsor:	CSL Behring (NZ) Limited
Manufacturer:	CSL Behring GmbH, Marburg, Germany

Dated this 6th day of July 2022.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

Tags

Notice Number

Schedule